These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8545956)

  • 1. Characteristics of equine herpesvirus 1 glycoproteins expressed in insect cells.
    Whalley JM; Love DN; Tewari D; Field HJ
    Vet Microbiol; 1995 Sep; 46(1-3):193-201. PubMed ID: 8545956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
    Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice.
    Packiarajah P; Walker C; Gilkerson J; Whalley JM; Love DN
    Vet Microbiol; 1998 Apr; 61(4):261-78. PubMed ID: 9646476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of equine herpesvirus-1 (EHV-1) glycoprotein B in a murine model of EHV-1-induced abortion.
    Kukreja A; Walker C; Fitzmaurice T; Awan A; Love DN; Whalley JM; Field HJ
    Vet Microbiol; 1998 Aug; 62(4):303-11. PubMed ID: 9791876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of glycoprotein B of equine herpesvirus 1 expressed by a recombinant baculovirus.
    Munro KI; Wellington JE; Love DN; Whalley JM
    Vet Microbiol; 1999 Aug; 68(1-2):49-57. PubMed ID: 10501161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the protective immunity of co-expressed glycoprotein H and L of equine herpesvirus-1 in a murine intranasal infection model.
    Kukreja A; Love DN; Whalley JM; Field HJ
    Vet Microbiol; 1998 Feb; 60(1):1-11. PubMed ID: 9595623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model.
    Tewari D; Whalley JM; Love DN; Field HJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1735-41. PubMed ID: 8021602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model.
    Tewari D; Nair SV; De Ungria MC; Lawrence GL; Hayden M; Love DN; Field HJ; Whalley JM
    Arch Virol; 1995; 140(4):789-97. PubMed ID: 7794119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
    Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterisation of equine herpesvirus 1 glycoprotein H using a recombinant baculovirus.
    McGowan EM; Hayden MB; Edwards SJ; Pye D; Love DN; Whalley JM
    Arch Virol; 1994; 137(3-4):389-95. PubMed ID: 7944958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of DNA-mediated vaccination for equine herpesvirus 1.
    Ruitenberg KM; Walker C; Wellington JE; Love DN; Whalley JM
    Vet Microbiol; 1999 Aug; 68(1-2):35-48. PubMed ID: 10501160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody.
    Ruitenberg KM; Love DN; Gilkerson JR; Wellington JE; Whalley JM
    Vet Microbiol; 2000 Sep; 76(2):117-27. PubMed ID: 10946142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2Kk) murine model.
    Stokes A; Cameron RS; Marshall RN; Killington RA
    Virus Res; 1997 Aug; 50(2):159-73. PubMed ID: 9282781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR-5 agonist Salmonella abortus equi flagellin FliC enhances FliC-gD-based DNA vaccination against equine herpesvirus 1 infection.
    Zhao Y; Chang J; Zhang B; Tong P; Wang C; Ran D; Su Y
    Arch Virol; 2019 May; 164(5):1371-1382. PubMed ID: 30888564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of recombinant equine herpesvirus 1 (EHV-1) replaced with passage-induced mutant gene 1 and gene 71 derived from an attenuated EHV-1 in cell cultures and in the lungs of mice.
    Kirisawa R; Kobayashi T; Uematsu R; Ikeda A; Kuroiwa R; Urakami A; Iwai H
    Vet Microbiol; 2003 Sep; 95(3):159-74. PubMed ID: 12935744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.
    Wagner B; Goodman LB; Babasyan S; Freer H; Torsteinsdóttir S; Svansson V; Björnsdóttir S; Perkins GA
    Vaccine; 2015 Oct; 33(42):5588-5597. PubMed ID: 26384446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
    Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
    Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.